n.a. (FURX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Shares Outstanding 10.82M
Div & Yield N.A. (N.A)

Latest News

Insider Trading Alert - FURX, EGP And FLT Traded By Insiders

Insider Trading Alert - FURX, EGP And FLT Traded By Insiders

Stocks with insider trader activity include FURX, EGP and FLT

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit In Connection With The Sale Of Furiex Pharmaceuticals, Inc. To Forest Laboratories, Inc. And Royal Empress, Inc.

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit In Connection With The Sale Of Furiex Pharmaceuticals, Inc. To Forest Laboratories, Inc. And Royal Empress, Inc.

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Chancery Court on behalf of all common stockholders of Furiex...

Furiex Pharmaceuticals Reports First Quarter 2014 Financial Results

Furiex Pharmaceuticals Reports First Quarter 2014 Financial Results

Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) today reported its financial and operating results for the quarter ended March 31, 2014.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Furiex Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Forest Laboratories, Inc.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Furiex Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Forest Laboratories, Inc.

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Furiex Pharmaceuticals, Inc.

INVESTOR ALERT – FURIEX PHARMACEUTICALS, INC.: The Law Offices Of Vincent Wong Investigates The Sale Of Furiex Pharmaceuticals, Inc.

INVESTOR ALERT – FURIEX PHARMACEUTICALS, INC.: The Law Offices Of Vincent Wong Investigates The Sale Of Furiex Pharmaceuticals, Inc.

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Furiex Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Furiex Pharmaceuticals, Inc. Buyout

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Furiex Pharmaceuticals, Inc. Buyout

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Furiex Pharmaceuticals, Inc.

FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Furiex Pharmaceuticals, Inc. (FURX) Over The Proposed Sale Of The Company To Forest Laboratories, Inc.

FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Furiex Pharmaceuticals, Inc. (FURX) Over The Proposed Sale Of The Company To Forest Laboratories, Inc.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Furiex Pharmaceuticals...

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Furiex Pharmaceuticals, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Furiex Pharmaceuticals, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Furiex Pharmaceuticals, Inc.

Why Furiex Pharmaceuticals (FURX) Stock Soared Today

Why Furiex Pharmaceuticals (FURX) Stock Soared Today

Furiex Pharmaceuticals (FURX) surged Monday after Forest Laboratories (FRX) announced it would acquire the company for $1.5 billion.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Furiex Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Forest Laboratories, Inc.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Furiex Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Forest Laboratories, Inc.

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Furiex Pharmaceuticals, Inc.

U.S. Stocks Mount Midday Turnaround to Close Higher, Bank of America Plunges

U.S. Stocks Mount Midday Turnaround to Close Higher, Bank of America Plunges

U.S. stocks turned around earlier losses Monday and closed in the green, while shares of banking giant Bank of America plunge on a capital blunder.

Furiex Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Forest Laboratories

Furiex Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Forest Laboratories

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Furiex...

Midday Report: Chinese Internet Stocks Left Out of U.S. Rally: StockTwits.com

Midday Report: Chinese Internet Stocks Left Out of U.S. Rally: StockTwits.com

Mergers heated up U.S. markets but Chinese Internet stocks were left out in the cold.

Forest Laboratories Inks $1.4B Deal for Furiex

Forest Laboratories Inks $1.4B Deal for Furiex

Forest Laboratories said Monday it has a deal to acquire Furiex Pharmaceuticals for upward of $1.4 billion, boosting its gastroenterology unit amid a wave of consolidation in the drug business.

FURIEX INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Furiex Pharmaceuticals, Inc. (FURX) Over The Proposed Sale Of The Company To Forest Laboratories, Inc.

FURIEX INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Furiex Pharmaceuticals, Inc. (FURX) Over The Proposed Sale Of The Company To Forest Laboratories, Inc.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Furiex Pharmaceuticals (“Furiex” or...